Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients
about
An update on the management of chronic lymphocytic leukaemia.Cladribine in combination with mitoxantrone and cyclophosphamide(CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies.Cladribine in the treatment of chronic lymphocytic leukemia.Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment.Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia.Management of chronic lymphocytic leukemia.Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosisTherapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies.Chronic cladribine administration increases amyloid beta peptide generation and plaque burden in mice.Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients.The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials.Cladribine: not just another purine analogue?Chronic lymphocytic leukemia: treatment options for patients with refractory disease.Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.A review of pharmacologic options for previously untreated chronic lymphocytic leukemia.Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis.Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribine.Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients.Successful treatment of leukaemia cutis with cladribine in a patient with B-cell chronic lymphocytic leukaemia.Changes in leukemic cell nuclei revealed by differential scanning calorimetry.
P2860
Q30341946-3690F0ED-FD78-44D1-A31E-DF8FBAA2EA30Q33337294-9172A6F6-C5B5-4C94-9275-F3356ADA025BQ33337860-D262BB50-FFA9-4125-8C64-3FFAB767C658Q33344377-C49D359B-2C7B-4A1E-BB35-6D83411C2DAFQ33375915-4E9083F5-62A7-4B30-B69C-D9FF73FB825EQ33695912-9B100031-99BE-4361-8A89-B25069B7ACF4Q33802186-A2800B3F-72D1-442F-81C5-9D7579F1F2D9Q34116907-B811A320-0B7E-42B6-AF8A-548219CD091CQ34441015-6A561488-8519-4170-A4C3-BA9A3EB065FEQ34620975-47FE37F4-77EA-4C9E-814E-59501412763AQ34632502-E5AC153C-26D4-4AAE-9796-A855293F251FQ34992373-5F822AC1-D1E1-4D78-A554-CBB67ED46F1CQ35382716-EF9167F4-AAF6-4CBE-8347-4C98A7DC0364Q36689156-0EA0FA6C-65B3-456D-B59B-274520C63635Q37424784-D14D4DE1-74D0-4AE0-87FF-C38E4B672889Q37677899-B34B5123-9529-41EF-968C-9A706703FED2Q38576523-B50648C4-2BFC-41BF-B0E4-B43F9564BC53Q43589595-6F06E1DB-3DC9-4467-A499-781E003B249BQ43621682-E67D6BDC-2581-4CB1-9708-B5993F7F1347Q43889349-0A8FAA84-569C-4396-964A-47615F9AB20FQ44169347-A18037EB-0E9A-42DA-9EBE-31ED0F517FE2Q45204153-A36AFEB9-B0F5-4FE9-8009-9F7D675D94B3
P2860
Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cladribine with or without pre ...... ticentre study of 378 patients
@ast
Cladribine with or without pre ...... ticentre study of 378 patients
@en
Cladribine with or without pre ...... ticentre study of 378 patients
@nl
type
label
Cladribine with or without pre ...... ticentre study of 378 patients
@ast
Cladribine with or without pre ...... ticentre study of 378 patients
@en
Cladribine with or without pre ...... ticentre study of 378 patients
@nl
prefLabel
Cladribine with or without pre ...... ticentre study of 378 patients
@ast
Cladribine with or without pre ...... ticentre study of 378 patients
@en
Cladribine with or without pre ...... ticentre study of 378 patients
@nl
P2093
P2860
P921
P1476
Cladribine with or without pre ...... ticentre study of 378 patients
@en
P2093
A B Skotnicki
A Dmoszyńska
A Hellmann
A Tomaszewska
B Ceglarek
B Zdziarska
J Dwilewicz-Trojaczek
J Holowiecki
J Z Bloński
P2860
P304
P356
10.1046/J.1365-2141.2000.01850.X
P407
P577
2000-02-01T00:00:00Z